The Risks Of Investing In Unilever plc

Royston Wild outlines the perils of stashing your cash in Unilever plc (LON: ULVR).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am highlighting what you need to know before investing in Unilever (LSE: ULVR) (NYSE: UL.US).

New markets continue to shake

Unilever’s sprawling presence across the globe gives it a terrific wingspan across Asia, Africa and Latin America amongst other lucrative places. So although the firm’s stableUnilever of industry leading brands is keeping the top-line moving in the right direction — sales from developing regions rose 6.6% during January-March — intensifying competition and deteriorating consumer spending power are causing activity to decelerate.

Indeed, growth during the period compares starkly with the 10.4% advance posted in the corresponding three months of 2013. Emerging markets account for more than 55% of group sales so signs of slowing till rolls here are a big deal for group revenues — these slipped 6.3% revenue during quarter one, to €11.4bn.

Europe remains a sticking point

But weakness in developing regions is not the only headache for Unilever, as poor trading conditions in Europe — responsible for more than a quarter of total turnover — continue to reign. The company saw sales stagnate during quarter one, rising just 0.1% while volumes advanced just 1.1%.

And latest data from Eurostat revealed that Unilever should not expect a solid improvement in shopping trends any time soon — aggregated retail sales in the 28 European Union states slipped 0.1% during May on seasonally-adjusted month-on-month basis

A dicey dividend outlook?

Despite a murky sales outlook, however, City analysts expect Unilever to grow last year’s dividend of 109.49 euro cents per dividend to 113.9 cents this year and again, to 122 cents, in 2015. These figures create yields of 3.5% and 3.7%, peeking above a FTSE 100 forward average of 3.3%.

Still, I believe that bare dividend coverage of just 1.4 times prospective earnings through to the end of next year — some way off the safety watermark of 2 times or above — should prompt some investor concern in my opinion.

And even though a series of brand divestments in recent months — particularly across its Foods division, like that of Slim Fast just last week — have boosted the balance sheet considerably, further dividend hikes could fail to materialise should sales weakness last. Net debt rose to €8.5bn last year from €7.4bn in 2012.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool owns shares of Unilever.

More on Investing Articles

Happy young female stock-picker in a cafe
Investing Articles

Q1 results boost the Bunzl share price: investors should consider the stock for stability

As the Bunzl share price edges higher, our writer considers whether this so-called boring FTSE 100 stock looks like a…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

The top 5 investment trusts to buy in a resurgent UK stock market?

These were the five most popular investment trusts at Hargreaves Lansdown in April. And they're not the ones I'd have…

Read more »

woman sitting in wheelchair at the table and looking at computer monitor while talking on mobile phone and drinking coffee at home
Investing Articles

The smartest dividend stocks to consider buying with £500 right now

In the past few years, the UK stock market’s been a great place to find dividend stocks paying top yields.…

Read more »

2024 year number handwritten on a sandy beach at sunrise
Investing Articles

Why this FTSE 100 company is the first I’m buying for my 24/25 Stocks and Shares ISA

As a new Stocks and Shares ISA year gets underway, it’s time to start searching for my next additions. Barclays…

Read more »

Investing Articles

How much passive income would I make from 945 National Grid shares?

National Grid shares pay a healthy dividend that, over time, can produce a sizeable passive income if the dividends are…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

These 7 UK shares turned £50k into £550k

Investing in individual UK shares can be a very lucrative strategy. Over the last two decades, these seven stocks have…

Read more »

Tanker coming in to dock in calm waters and a clear sunset
Investing Articles

Up 14% in a day! Is this embattled FTSE 250 company on the road to recovery?

The sudden price surge in a lesser-known FTSE 250 stock caught my attention today. I decided to find out what’s…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Is this FTSE growth superstar set to soar even higher on new drug results?

New drugs should significantly boost this FTSE stock’s earnings in my view. But even without them it looked very undervalued…

Read more »